Authors:
SIEGEL EG
GALLWITZ B
FOLSCH UR
SCHMIDT WE
Citation: Eg. Siegel et al., EFFECT OF HUMAN PANCREASTATIN PEPTIDE (HP-16) ON ORAL GLUCOSE-TOLERANCE IN MAN, EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 106(3), 1998, pp. 178-182
Citation: Eg. Siegel et al., SEVERE ISCHEMIC-TYPE BILIARY STRICTURES DUE TO HEPATIC-ARTERY OCCLUSION 7 YEARS AFTER LIVER-TRANSPLANTATION - A RARE CAUSE OF LATE CHOLESTATIC GRAFT FAILURE, Zeitschrift fur Gastroenterologie, 36(6), 1998, pp. 509-513
Authors:
SIEGEL EG
GALLWITZ B
SCHMITZ F
SEIDENSTUCKER A
CLEMENS A
FEYERABEND B
FOLSCH UR
SCHMIDT WE
Citation: Eg. Siegel et al., GLP-I(7-36AMIDE) INCREASES INSULIN-SECRETION FROM PANCREATIC-ISLETS IN CIRRHOTIC RATS, Gastroenterology, 114(4), 1998, pp. 2034-2034
Authors:
VERING T
ADAM S
DREWER H
DUMSCHAT C
STEINKUHL R
SCHULZE A
SIEGEL EG
KNOLL M
Citation: T. Vering et al., WEARABLE MICRODIALYSIS SYSTEM FOR CONTINUOUS IN-VIVO MONITORING OF GLUCOSE, Analyst (London. 1877. Print), 123(7), 1998, pp. 1605-1609
Authors:
SCHAFER H
ZHENG J
GUNDLACH F
GUNTHER R
SIEGEL EG
FOLSCH UR
SCHMIDT WE
Citation: H. Schafer et al., PITUITARY ADENYLATE-CYCLASE-ACTIVATING POLYPEPTIDE STIMULATES PROTOONCOGENE EXPRESSION AND ACTIVATES THE AP-1 (C-FOS C-JUN) TRANSCRIPTION FACTOR IN AR4-2J PANCREATIC-CARCINOMA CELLS/, European journal of biochemistry, 242(3), 1996, pp. 467-476
Authors:
SCHAFER H
TRAUZOLD A
SIEGEL EG
FOLSCH UR
SCHMIDT WE
Citation: H. Schafer et al., PRG1 - A NOVEL EARLY-RESPONSE GENE TRANSCRIPTIONALLY INDUCED BY PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE IN A PANCREATIC-CARCINOMA CELL-LINE, Cancer research, 56(11), 1996, pp. 2641-2648
Authors:
MEYERALBER A
SIEGEL EG
FORNEFELD H
FOLSCH UR
SCHMIDT WE
Citation: A. Meyeralber et al., PROTEIN-TYROSINE-PHOSPHATASE INHIBITOR ORTHOVANADATE AFFECTS DIFFERENT LEVELS OF PANCREATIC ACINAR SIGNAL-TRANSDUCTION CASCADES IN THE RAT, Gastroenterology, 108(4), 1995, pp. 375-375
Authors:
NAUCK MA
BUSING M
ORSKOV C
SIEGEL EG
TALARTSCHIK J
BAARTZ A
BAARTZ T
HOPT UT
BECKER HD
CREUTZFELDT W
Citation: Ma. Nauck et al., PRESERVED INCRETIN EFFECT IN TYPE-1 DIABETIC-PATIENTS WITH END-STAGE NEPHROPATHY TREATED BY COMBINED HETEROTOPIC PANCREAS AND KIDNEY-TRANSPLANTATION, Acta diabetologica, 30(1), 1993, pp. 39-45